Letronat Tablet

By Letronat

Rx

10 Tablet in a Strip

Composition icon

Composition

Letrozole(2.5mg)

Manufacturer - Natco Pharma Ltd icon

Manufacturer - Natco Pharma Ltd

Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India

Expires on or after icon

Expires on or after

January, 2027

About Letronat Tablet

Let's introduce the Letronat Tablet in a comprehensive and easy-to-understand manner, focusing on its uses, benefits, side effects, and precautions.

Letronat Tablet is a medication primarily used in the treatment of breast cancer in post-menopausal women. It can be utilized either independently or in conjunction with other therapies such as surgery or radiation. Furthermore, Letronat Tablet is effective in patients with advanced breast cancer, helping to prevent the spread of tumors to other parts of the body. This anti-cancer medicine falls under the category of aromatase inhibitors, specifically containing Letrozole as its active component.

Breast cancer is a type of cancer that originates in breast cells, often influenced by the hormone estrogen. By targeting the aromatase enzyme responsible for estrogen production, Letronat Tablet impedes the growth of cancer cells reliant on estrogen for proliferation. Through this mechanism, Letronat Tablet aids in halting the spread and growth of tumors, safeguarding against further advancement of cancer cells throughout the body.

It is essential to follow your doctor's guidance regarding the dosage and duration of Letronat Tablet treatment tailored to your specific medical requirements. While taking this medication, common side effects may occur, including hot flashes, fatigue, increased sweating, joint pain, dizziness, and flushing. Should these side effects persist or become bothersome, it is crucial to promptly inform your healthcare provider for appropriate guidance and potential solutions.

Prior to initiating Letronat Tablet, inform your doctor about any history of liver or kidney issues, or past occurrences of conditions like osteoporosis. Additionally, disclose all other medications you are currently taking to prevent any potential interactions that may affect the efficacy of Letronat Tablet. Pregnant or breastfeeding women should avoid Letronat Tablet due to possible risks to the developing baby. Regular monitoring through blood tests for vitamin D levels and bone density may be recommended by your doctor during the course of treatment to ensure optimal results and safety.

Letronat Tablet offers a promising approach in the management of breast cancer, emphasizing the importance of adherence to prescribed guidelines and open communication with healthcare professionals for a well-informed and effective treatment journey.


Benefits

Letronat Tablet offers several benefits for patients undergoing treatment for breast cancer and infertility due to anovulation. When used in the treatment of breast cancer, this medication effectively relieves symptoms such as breast lumps, bloody discharge from the nipple, and changes in the shape or texture of the breast. It works by targeting the hormones crucial for the growth and spread of breast cancer. By altering hormone production, Letronat Tablet may also interact with other hormones or directly impact cancer cells to inhibit their growth, ultimately aiding in the management of breast cancer.


In cases of infertility due to anovulation, Letronat Tablet plays a key role in facilitating the normal development of an egg within a woman's ovary and promoting the release of the egg through ovulation. This mechanism increases the chances of successful conception and pregnancy in women struggling with infertility. It is important to adhere to the prescribed dosage and usage instructions to ensure the optimal effectiveness of Letronat Tablet in addressing infertility issues.


Belonging to the class of aromatase inhibitors, Letronat Tablet is specifically designed to treat breast cancer in postmenopausal women. By blocking the aromatase enzyme responsible for estrogen production, this medication hinders the estrogen-dependent growth of cancer cells. Consequently, Letronat Tablet helps to impede the progression of tumours, slowing down their growth and preventing their spread to other parts of the body. Overall, the targeted action of Letronat Tablet offers significant benefits in combating breast cancer and infertility related to anovulation, providing patients with effective treatment options for these conditions.


How to use the Letronat Tablet

To properly use Letronat Tablet, follow the guidance provided by your doctor. Swallow the tablet whole with a glass of water; do not crush, chew, or break it. It is recommended to take Letronat Tablet at the same time each day for best results. You can take this medication with or without food, but it is advisable to establish a fixed routine for taking it. Your physician will determine the appropriate dosage and duration of treatment based on factors such as your age, weight, and the specific condition being treated. Be sure to adhere to your doctor's instructions precisely to ensure the medication is effective and safe for you.


Uses of Letronat Tablet

Letronat Tablet is commonly used for two main purposes. The first is for the treatment of breast cancer in postmenopausal women. It can be used as an initial therapy for breast cancer or following treatment with other medications like tamoxifen. Additionally, Letronat Tablet is also utilized in the management of infertility due to anovulation.


What conditions Letronat Tablet treats?

Breast cancer is a form of cancer that originates in the cells of the breast. It can develop in the lobules, ducts, fatty tissue, or connective tissue of the breast. The cancer cells have the ability to spread to lymph nodes and other parts of the body. Common symptoms include a noticeable lump in the breast, changes in breast shape or size, skin abnormalities, and swelling under the arm. Breast cancer is often influenced by estrogen, a hormone found in females.


Should you consult a doctor?

If you have not yet experienced menopause, it is important to avoid using Letronat Tablet. Before starting this medication, it is crucial to inform your doctor if you have a history of bone fractures, osteoporosis (which causes weak bones), or joint inflammation. Seeking a doctor's advice becomes necessary if you have any of these conditions, to ensure the safe use of Letronat Tablet and to avoid any potential complications that may arise.


Side effects of Letronat Tablet

Letronat Tablet may cause various side effects while your body adjusts to the medication. These side effects are usually not severe and tend to go away on their own. If they persist or if you are concerned about them, it is advisable to consult your doctor. Some common side effects of Letronat Tablet include fatigue, hypercholesterolemia (high cholesterol levels), increased sweating, hot flashes, bone pain, dizziness, joint pain, edema (swelling), and flushing (a warm sensation in the face, ears, neck, and trunk). You may also experience tiredness, weakness, feeling unwell, pain in joints, and hot flushes. Other potential side effects include anxiety, nervousness, irritability, drowsiness, memory problems, insomnia, pain or burning sensation in the hands or wrist (carpal tunnel syndrome), impaired sensation of touch, tingling or numbness, vaginal discharge or dryness, breast pain, thirst, taste disorder, dry mouth, weight loss, urinary tract infection, increased frequency of urination, cough, inflammation of the mouth and lips (stomatitis), feeling weak or tired, muscle pain, skin rash, headache, nausea, vomiting, indigestion, constipation, diarrhea, loss of appetite, swelling of arms, hands, feet, or ankles, weight gain, depression, hair loss, dry skin, vaginal bleeding, and palpitations (rapid heartbeat). If you experience any of these side effects and they persist or worsen, seek medical advice promptly.


Safety advice

scroll

liver

When taking Letronat Tablet, it is important to be cautious if you have liver disease. It may be necessary to adjust the dosage of Letronat Tablet based on your liver condition. It is advisable to consult your doctor for guidance on the appropriate use of this medication if you have any liver issues.

scroll

kidney

Letronat Tablet is generally safe for patients with kidney disease. No dose adjustment is needed. However, limited data exists for end-stage kidney disease. Consult your doctor for guidance.

scroll

alcohol

It is safe to consume alcohol with Letronat Tablet as it does not have harmful side effects.

scroll

driving

When taking Letronat Tablet, be cautious while driving as it may reduce alertness, impact vision, and cause drowsiness or dizziness. Avoid driving if experiencing these side effects.

scroll

pregnancy

Letronat Tablet is not safe to use during pregnancy. Studies have shown harmful effects on the developing baby in pregnant women and animals. Please consult your doctor for advice.

scroll

breastfeeding

Letronat Tablet is not safe for breastfeeding, as it can cause toxicity to the baby. It is better to consult your doctor before using Letronat Tablet during breastfeeding.


Age above 75(Geriatrics)

Letronat Tablet should be used with caution in elderly patients (aged 65 years or older). Therefore, consult your doctor before taking it.


Age below 6 months(Pediatrics)

Letronat Tablet is not recommended for use in children and adolescents (aged below 18 years). Therefore, consult your doctor before taking it.


Consumption warning before consuming Letronat Tablet

Before consuming Letronat Tablet 5's, be cautious if you have allergies to its ingredients or have not yet undergone menopause. Consult your doctor if you have osteoporosis, bone fractures, or serious liver or kidney issues. Watch out for signs of tendon pain or swelling as Letronat Tablet 5's may cause tendon inflammation or injury. Avoid this medication during pregnancy or breastfeeding. Due to potential drowsiness and dizziness, drive only when fully alert. Letronat Tablet 5's should not be given to children. Combining this medication with alcohol may intensify drowsiness and dizziness. Inform your doctor about your health status and current medications to prevent any adverse reactions.


Disease interactions

When taking Letronat Tablet, it is crucial to inform your doctor if you have certain medical conditions. Make sure to let your healthcare provider know if you have high cholesterol, osteoporosis (thinning of bone), or liver disease. Sharing this information is essential because these conditions may have interactions with the medication. By informing your doctor about your specific health situation, they can provide you with the most appropriate guidance and necessary adjustments to ensure your health and safety while taking Letronat Tablet.


What if you forgot to take Letronat Tablet?

If you forget to take a dose of Letronat Tablet, try to take it as soon as you remember. However, if it's almost time for your next scheduled dose, then skip the missed dose and continue with your normal dosing routine. Avoid taking a double dose to make up for the missed one. It's important to stick to your prescribed dosage schedule to maintain the effectiveness of the medication. If you have any concerns about missed doses or how to manage them, consult your healthcare provider for guidance.


Related lab tests

Related Lab Tests for breast cancer management include testing for CA 15.3, ER (Estrogen Receptor), and PR (Progesterone Receptor) levels. CA 15.3 is a tumor marker that can help monitor the progression or regression of breast cancer. ER and PR are hormone receptors that play a crucial role in determining the effectiveness of hormonal therapy in treating breast cancer. Testing for these receptors helps doctors tailor the treatment plan according to the individual's hormone receptor status. Regular monitoring of CA 15.3, ER, and PR levels through blood tests can provide valuable information for assessing the response to treatment and making necessary adjustments to improve outcomes. These lab tests are essential tools in the comprehensive management of breast cancer.


Additional Information

Habit FormingNo
Chemical ClassDiphenylmethane Derivative
Therapeutic ClassANTI NEOPLASTICS
Action ClassAromatase inhibitor

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

208

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 18-Nov-2024